Additive Beneficial Effects of Atorvastatin Combined With Amlodipine In Treatment of Hypertension
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The investigators hypothesized combination therapy would be superior to monotherapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Dec 2004
Longer than P75 for phase_4 hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2004
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2008
CompletedFirst Submitted
Initial submission to the registry
August 20, 2008
CompletedFirst Posted
Study publicly available on registry
August 26, 2008
CompletedAugust 29, 2008
August 1, 2008
August 20, 2008
August 28, 2008
Conditions
Keywords
Study Arms (1)
atorvastatin, amlodipine
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Hypertension
You may not qualify if:
- Chronic renal disease
- Severe hypertension
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gil Medical Center
Incheon, 405-760, South Korea
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 20, 2008
First Posted
August 26, 2008
Study Start
December 1, 2004
Study Completion
August 1, 2008
Last Updated
August 29, 2008
Record last verified: 2008-08